lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Pre-Clinical Study of Iron Nanoparticles Fortified Artesunate for Efficient Targeting of Malarial Parasite

38 Pages Posted: 23 Jan 2019

See all articles by Deepika Kannan

Deepika Kannan

Shiv Nadar University

Nisha Yadav

Shiv Nadar University - Department of Chemistry

Shakeel Ahmad

Jawaharlal Nehru University - Special Center for Molecular Medicine

Bimlesh Lochab

Shiv Nadar University - Department of Chemistry

Shailja Singh

Jawaharlal Nehru University - Special Center for Molecular Medicine

More...

Abstract

Background: Artesunate the most potent antimalarial is widely used for the treatment of multidrug-resistant malaria. The antimalarial cytotoxicity of Artesunate has been mainly attributed to its selective, irreversible and iron-catalyzed radical mediated damage of parasite biomolecules. In the present research, iron nanoparticle fortified artesunate was tested in P. falciparum and in an experimental malaria mouse model for enhancement in the selectivity and toxicity of Artesunate towards parasite. Artesunate was fortified with nontoxic biocompatible surface modified iron nanoparticle which is specially designed and synthesized for sustained pH-dependent release of Fe2+ within the parasitic food vacuole for enhanced ROS spurt.

Methods: Antimalarial efficacy of Iron nanoparticle fortified Artesunate was evaluated in Plasmodium falciparum culture grown in O +ve human blood and in Plasmodium berghei ANKA infected swiss albino mice. Infected mice were daily administered intraperitoneally with Artesunate, nanoparticle fortified Artesunate and monitored for parasitemia. Internalization of iron nanoparticles, pH dependent release of Fe2+, production of reactive oxygen species and parasite biomolecule damage by iron nanoparticle fortified Artesunate was studied using various biochemical, biophysical, ultra-structural and fluorescence microscopy.

Results: The nanoparticle fortified Artesunate was highly efficient in 1/8th concentration of Artesunate IC50 and led to retarded growth of P. falciparum with significant damage to macromolecules mediated via enhanced ROS production. Similarly, preclinical In vivo studies also signified a radical reduction in parasitemia with ~8-10-fold reduced dosage of Artesunate when fortified with iron nanoparticles.

Interpretation: Surface coated iron-nanoparticle fortified Artesunate can be developed into a potent therapeutic agent towards multidrug-resistant malaria in humans.

Funding Statement: This study is supported by Center for Study of Complex malaria in India funded by National Institute of Health, USA, and by Department of Science and Technology (DST-INDIA) and LRE JNU. DK and NY are supported by Shiv Nadar Foundation fellowships. SA is funded by ICMR, Government of India.

Declaration of Interests: The authors declare that there are no conflicts of interest.

Ethics Approval Statement: Animal studies were performed in accordance with guidelines of the Institutional Animal Ethics Committee (IEAC) of Jawaharlal Nehru University, Delhi and Committee for Control and Supervision of Experiments on Animals (CPCSEA).

Keywords: Malaria; iron oxide nanoparticle; Artesunate; oxidative stress; protein carbonylation; DNA damage; multi-drug resistant malaria

Suggested Citation

Kannan, Deepika and Yadav, Nisha and Ahmad, Shakeel and Lochab, Bimlesh and Singh, Shailja, Pre-Clinical Study of Iron Nanoparticles Fortified Artesunate for Efficient Targeting of Malarial Parasite (January 16, 2019). 10.1016/j.ebiom.2019.06.026. Available at SSRN: https://ssrn.com/abstract=3320134

Deepika Kannan

Shiv Nadar University

NH-91, Village- Chithera, Tehsil-Dadri,
Dist. Gautam Buddha Nagar, UP
Gautam Buddha Nagar, Uttar Pradesh
India

Nisha Yadav

Shiv Nadar University - Department of Chemistry

NH-91, Village- Chithera, Tehsil-Dadri,
Dist. Gautam Buddha Nagar, UP
Gautam Buddha Nagar, Uttar Pradesh
India

Shakeel Ahmad

Jawaharlal Nehru University - Special Center for Molecular Medicine

Vasant Vihar
New Delhi, Delhi 110067
India

Bimlesh Lochab

Shiv Nadar University - Department of Chemistry ( email )

NH-91, Village- Chithera, Tehsil-Dadri,
Dist. Gautam Buddha Nagar, UP
Gautam Buddha Nagar, Uttar Pradesh
India

Shailja Singh (Contact Author)

Jawaharlal Nehru University - Special Center for Molecular Medicine ( email )

Vasant Vihar
New Delhi, Delhi 110067
India

Click here to go to TheLancet.com

Go to TheLancet.com

Paper statistics

Abstract Views
61
Downloads
12